Primary leiomyosarcoma of saphenous vein presenting as deep venous thrombosis

Vascular ◽  
2013 ◽  
Vol 22 (6) ◽  
pp. 450-453 ◽  
Author(s):  
Daniel I Fremed ◽  
Peter L Faries ◽  
Harry R Schanzer ◽  
Michael L Marin ◽  
Windsor Ting

Only a small number of venous leiomyosarcomas have been previously reported. Of these tumors, those of saphenous origin comprise a minority of cases. A 59-year-old man presented with symptoms of deep vein thrombosis and was eventually diagnosed with primary leiomyosarcoma of great saphenous vein origin. The tumor was treated with primary resection and femoral vein reconstruction with autologous patch. Although extremely rare, saphenous leiomyosarcoma can present as deep vein thrombosis. Vascular tumors should be included in the differential diagnosis of atypical extremity swelling refractory to conventional deep vein thrombosis management.

2006 ◽  
Vol 32 (3) ◽  
pp. 341
Author(s):  
P. Jothishankar ◽  
S. Maikandanathan ◽  
S.C. Hardy ◽  
R.A. Salaman

2021 ◽  
pp. 1-4
Author(s):  
Zierau UT

The thrombosis in areas of the superficial truncal varicose veins and cutaneous veins is not a rare complication; it requires drug or surgical therapy if the thrombosis grows in the direction of deep veins. This situation is particularly striking in the case of thromboses of the great saphenous vein GSV and small saphenous vein SSV as well as other saphenous veins and leads to deep vein thrombosis in around 20% of cases. We will report about a case of SSV thrombosis and the catheter-based therapy of thrombosis following the therapy of truncal varicose vein SSV with VenaSeal® in one session.


2018 ◽  
Vol 11 (1) ◽  
pp. 130-133
Author(s):  
Akiko Okunaga ◽  
Yuichi Oshima ◽  
Isao Yasui ◽  
Saki Ikuma ◽  
Norifumi Higashidani ◽  
...  

EJVES Extra ◽  
2006 ◽  
Vol 12 (1) ◽  
pp. 9-11
Author(s):  
P. Jothishankar ◽  
S. Maikandanathan ◽  
S.C. Hardy ◽  
R.A. Salaman

2021 ◽  
Vol 74 (10) ◽  
pp. 2620-2623
Author(s):  
Ivan I. Hadzheha

The aim: To evaluate the effectiveness of surgical treatment of varicothrombophlebitis complicated by transfascial thrombosis. Materials and methods: The results of examination and treatment of 45 patients with varicothrombophlebitis of the great saphenous vein complicated by transfascial thrombosis. Results: The indications for surgical prophylaxis of pulmonary embolism in transfascial thrombosis in the basin of the great saphenous vein have been substantiated. In the postoperative period, all patients with transfascial thrombosis, regardless of the radical nature of the surgical intervention, were offered to prescribe treatment as in deep vein thrombosis. The introduction of active surgical tactics in transfascial thrombosis allows for effective prevention of pulmonary embolism. Conclusions: In varicothrombophlebitis complicated by transfascial thrombosis, thrombectomy with further prevention of recurrence of the disease and pulmonary embolism should be considered the main standard of treatment. For perforating vein thrombosis, subfascial thrombectomy followed by perforating ligation should be performed. All patients with transfascial thrombosis, regardless of the volume of surgery, should be treated as for deep vein thrombosis.


2005 ◽  
Vol 94 (09) ◽  
pp. 498-503 ◽  
Author(s):  
Linda Szema ◽  
Chao-Ying Chen ◽  
Jeffrey P. Schwab ◽  
Gregory Schmeling ◽  
Brian C. Cooley

SummaryDeep vein thrombosis (DVT) occurs with high prevalence in association with a number of risk factors, including major surgery, trauma, obesity, bed rest (>5 days), cancer, a previous history of DVT, and several predisposing prothrombotic mutations. A novel murine model of DVT was developed for applications to preclinical studies of transgenically constructed prothrombotic lines and evaluation of new antithrombotic therapies. A transient direct-current electrical injury was induced in the common femoral vein of adult C57Bl/6 mice. A non-occlusive thrombus grew, peaking in size at 30 min, and regressing by 60 min, as revealed by histomorphometric volume reconstruction of the clot. Pre-heparinization greatly reduced clot formation at 10, 30, and 60 min (p<0.01 versus non-heparinized). Homozygous FactorV Leiden mice (analogous to the clinical FactorV Leiden prothrombotic mutation) on a C57Bl/6 background had clot volumes more than twice those of wild-types at 30 min (0.121±0.018 mm3 vs. 0.052±0.008 mm3, respectively; p<0.01). Scanning electron microscopy revealed a clot surface dominated by fibrin strands, in contrast to arterial thrombi which showed a platelet-dominated structure. This new model of DVT presents a quantifiable approach for evaluating thrombosis-related murine transgenic lines and for comparatively evaluating new pharmacologic approaches for prevention of DVT.


2018 ◽  
Vol Volume 14 ◽  
pp. 129-135 ◽  
Author(s):  
Samuel H Kim ◽  
Nimesh Patel ◽  
Kanika Thapar ◽  
Ananda V Pandurangadu ◽  
Amit Bahl

Sign in / Sign up

Export Citation Format

Share Document